Stay updated on APL-2 in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.
Latest updates to the APL-2 in Neovascular AMD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe website has been updated from version v2.13.2 to v2.13.3.SummaryDifference0.1%
- Check19 days agoChange DetectedThe website has updated the contact details section for the study, now providing information on who to contact for questions about joining the study and where it is taking place, reflecting a revision from v2.12.2 to v2.13.2.SummaryDifference3%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedThe website has added new features while removing extensive options for downloading study data, including various file formats and detailed data fields.SummaryDifference5%
- Check41 days agoChange DetectedSeveral key health-related links have been removed, including those related to genetics and macular degeneration, which may impact access to important medical information.SummaryDifference0.6%
- Check48 days agoChange DetectedThe website has been updated to Revision v2.12.2, with several new resources added, including links to MedlinePlus and ClinicalTrials.gov, as well as new data fields for study information.SummaryDifference6%
- Check56 days agoChange DetectedThe website has been updated from version 2.12.0 to 2.12.1.SummaryDifference0.1%
Stay in the know with updates to APL-2 in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the APL-2 in Neovascular AMD Clinical Trial page.